Board of Directors

Each member of our distinguished Board of Directors has extensive, exemplary experience in growing companies in the field of biologics. They are committed to providing an independent and objective source of counsel and to helping guide GBI in its mission as we continue to develop and manufacture highly complex, targeted biopharmaceuticals in a cost-effective and timely manner.

Karl Pinto, Executive Chairman & Chairman of the Board at GBI
Karl Pinto, MBA Executive Chairman & Chairman of the Board
Darrin T. Schellin, Chief Executive Officer at GBI
Darrin T. Schellin Chief Executive Officer
Divya Menezes, Board Member at GBI
Divya Menezes, MD Board Member
Kent Payne, Board Member at GBI
Kent Payne, Ph.D. Board Member
Brandon J. Price, Board Member at GBI
Brandon J. Price, Ph.D. Board Member
Nikhil Puri, Board Member at GBI
Nikhil Puri Board Member